Top 25 Tenaya Therapeutics investors
The most complete profiles first. Showing 25 of 25.
David GoeddelVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Joshua KennedyVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Krishna YeshwantVerified
Venture Capital, Corporate Venture Capital, Investor · United States
Series BHealth CareTelecommunicationsHospitalsE-commercePortfolio: Pixie, Dialpad, Science 37, Synack and 90 more
Verified email available
Peter SvennilsonVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Stephanie A. SirotaVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsEnterprise SoftwareInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Eric ThompsonVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
John AvirettVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
John WuestlingVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Karim FarisVerified
Venture Capital, Corporate Venture Capital · United States
Health CareTelecommunicationsE-commerceConsumer GoodsPortfolio: Pixie, Dialpad, Science 37, Synack and 87 more
Verified email available
Stephen WestVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Naveen Yalamanchi
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Piratip Pratumsuwan
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Roderick Wong
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Sabera Loughran
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Tim Kutzkey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Tony Nguyen
Hedge Fund, Venture Capital, Investor · United States
Series BAdvertisingHealth CareGeneticsInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Adeline Oursler
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
C. Ashton Newhall
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Cody Tranbarger
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Deric Emry
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
JJ Kang
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
James Evangelista
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Lindsay Redfield
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Todd Ruppert
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Tenaya Therapeutics investors are on Angel Roster?
Angel Roster lists 25 Tenaya Therapeutics investors. 11 of them (44%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (23), Secondary Purchaser Investors (8) and Funds of Funds (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Tenaya Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (8) and Seed (4).
Where are Tenaya Therapeutics investors based?
Most are based in the United States (25).
Which companies have Tenaya Therapeutics investors backed?
The most-backed portfolio companies among them are Kallyope (16), NGM Biopharmaceuticals (13), Orchard Therapeutics (10), NiKang Therapeutics (10) and Encoded Therapeutics (9).
How do I contact Tenaya Therapeutics investors?
Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.